Literature DB >> 2136070

Comparative effectiveness of carbamazepine and propranolol for rage outbursts.

J A Mattes1.   

Abstract

Eighty patients (randomly assigned in 51 cases) with diverse diagnoses, were prescribed propranolol or carbamazepine for temper outbursts. Results suggested that both medications were beneficial. The diagnosis of attention deficit disorder predicted preferential response to propranolol, and a diagnosis of intermittent explosive disorder predicted preferential response to carbamazepine. Results, however, were not entirely consistent and require confirmation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136070     DOI: 10.1176/jnp.2.2.159

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  6 in total

Review 1.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat Khalifa; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 2.  Intermittent explosive disorder.

Authors:  E F Coccaro
Journal:  Curr Psychiatry Rep       Date:  2000-02       Impact factor: 5.285

Review 3.  Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Authors:  Silvio Bellino; Erika Paradiso; Filippo Bogetto
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Prevalence of DSM-IV intermittent explosive disorder in Black adolescents: Findings from the National Survey of American Life, Adolescent Supplement.

Authors:  Diane Graves Oliver; Cleopatra H Caldwell; Nakesha Faison; Julie A Sweetman; Jamie M Abelson; James S Jackson
Journal:  Am J Orthopsychiatry       Date:  2016-04-14

5.  A neuropsychiatry service in a state hospital. Adolf Meyer's approach revisited.

Authors:  Joseph Tonkonogy; Jeffrey Geller
Journal:  Psychiatr Q       Date:  2007-09

6.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat R Khalifa; Simon Gibbon; Birgit A Völlm; Natalie H-Y Cheung; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.